RxSight (RXST) Leases (2020 - 2026)

RxSight (RXST) has 7 years of Leases data on file, last reported at $9.8 million in Q1 2026.

• For the quarter ending Q1 2026, Leases fell 10.64% year-over-year to $9.8 million; the trailing twelve-month figure through Mar 2026 stood at $9.8 million (down 10.64% YoY), and the FY2025 full-year result was $10.0 million, down 11.22% from the prior year.
• Leases for Q1 2026 stood at $9.8 million, down from $10.0 million in the prior quarter.
• Across five years, Leases topped out at $11.2 million in Q4 2024 and bottomed at $2.1 million in Q1 2024.
• The 5-year median for Leases is $4.7 million (2022), against an average of $6.8 million.
• The widest annual swing landed in 2024, when Leases slumped 42.28%; it then soared 432.26% in 2025.
• A 5-year view of Leases shows it stood at $3.9 million in 2022, then tumbled by 38.02% to $2.4 million in 2023, then soared by 358.96% to $11.2 million in 2024, then retreated by 11.22% to $10.0 million in 2025, then retreated by 2.0% to $9.8 million in 2026.
• The last three Leases figures came in at $9.8 million (Q1 2026), $10.0 million (Q4 2025), and $10.3 million (Q3 2025), per Business Quant data.

Peer Comparison